SLC16A13 and type 2 diabetes mellitus: Since the human phenotype associated with the SLC16A13 polymorphisms reflects higher susceptibility to T2D, we hypothesized that changes in SLC16A13 abundance will affect hepatic lipid deposition and insulin sensitivity.